B Kest - JoVE Visualize

Showing results (21-30 of 39) with videos related to

Pageof 4

Sort By:

Psychopharmacology|January 1, 1987

Reduction in 2-deoxy-D-glucose analgesia following acute, but not chronic antidepressant treatmentR J Bodnar, M T Romero, B Kest, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1995

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug developmentK Elliott, B Kest, A Man, et al.

Life Sciences|January 1, 1997

Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1)B Kest, C E Lee, J S Mogil, et al.

European Journal of Pharmacology|May 21, 1998

Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociceptionB Kest, C E Lee, S Jenab, et al.

Pharmacology, Biochemistry, and Behavior|September 1, 1989

Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in ratsK L Kepler, B Kest, J M Kiefel, et al.

Pharmacology, Biochemistry, and Behavior|September 1, 1995

1,3-Di-o-tolylguanidine (DTG) differentially affects acute and tonic formalin pain: antagonism by rimcazoleB Kest, J S Mogil, W F Sternberg, et al.

Pharmacology, Biochemistry, and Behavior|April 1, 1995

Antinociception following 1,3,-di-o-tolylguanidine, a selective sigma receptor ligandB Kest, J S Mogil, W F Sternberg, et al.

Neuroscience|November 8, 2002

Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependenceB Kest, C A Palmese, E Hopkins, et al.

Pharmacology, Biochemistry, and Behavior|July 1, 1987

Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesiaB C Yoburn, L S Truesdell, B Kest, et al.

Brain Research|July 2, 1993

NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalinA L Vaccarino, P Marek, B Kest, et al.

Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:

Pageof 4

Psychopharmacology|January 1, 1987

Reduction in 2-deoxy-D-glucose analgesia following acute, but not chronic antidepressant treatmentR J Bodnar, M T Romero, B Kest, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1995

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug developmentK Elliott, B Kest, A Man, et al.

Life Sciences|January 1, 1997

Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1)B Kest, C E Lee, J S Mogil, et al.

European Journal of Pharmacology|May 21, 1998

Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociceptionB Kest, C E Lee, S Jenab, et al.

Pharmacology, Biochemistry, and Behavior|September 1, 1989

Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in ratsK L Kepler, B Kest, J M Kiefel, et al.

Pharmacology, Biochemistry, and Behavior|September 1, 1995

1,3-Di-o-tolylguanidine (DTG) differentially affects acute and tonic formalin pain: antagonism by rimcazoleB Kest, J S Mogil, W F Sternberg, et al.

Pharmacology, Biochemistry, and Behavior|April 1, 1995

Antinociception following 1,3,-di-o-tolylguanidine, a selective sigma receptor ligandB Kest, J S Mogil, W F Sternberg, et al.

Neuroscience|November 8, 2002

Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependenceB Kest, C A Palmese, E Hopkins, et al.

Pharmacology, Biochemistry, and Behavior|July 1, 1987

Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesiaB C Yoburn, L S Truesdell, B Kest, et al.

Brain Research|July 2, 1993

NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalinA L Vaccarino, P Marek, B Kest, et al.

Pageof 4